Acrivon Therapeutics, Inc. [ACRV]

Source: 

Company Overview

Acrivon is a clinical stage biopharmaceutical company developing precision oncology medicines that we match to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing our proprietary proteomics-based patient responder identification platform.